The Luteal Phase: Meaning, Length, Symptoms and Progesterone
The luteal phase is the second half of the menstrual cycle: it begins on the day you ovulate and ends when your next period starts, or when an early pregnancy takes over hormone production. The name comes from the corpus luteum, the temporary hormone-producing structure that forms in the ovary from the follicle that has just released an egg. For most women the luteal phase lasts between 11 and 16 days, and it is considerably more consistent in length than the first half of the cycle. During these days progesterone rises steeply, the lining of the uterus is remodelled so that it can accept an embryo, and most of the physical and emotional changes people describe as premenstrual appear.
Most searches about luteal phase symptoms come from women noticing a predictable pattern: breast tenderness, bloating, a change in discharge, disturbed sleep and a shift in mood that arrives after ovulation and clears within a day or two of bleeding. In the majority of cases these changes are physiological rather than a sign of disease. They reflect progesterone acting on breast tissue, bowel, skin, brain and cervix at the same time. What matters clinically is the pattern rather than the presence of symptoms: cyclical, self-limiting complaints that settle with menstruation behave very differently from symptoms that persist throughout the month, and the two are investigated in different ways.
For anyone trying to conceive, the luteal phase carries additional weight, because implantation happens inside it. The endometrium is receptive only for a short window, usually somewhere around six to ten days after ovulation, and that window depends on adequate progesterone exposure in the preceding days. This is why a persistently short luteal phase, heavy premenstrual spotting or an unexpectedly early period raises the question of a luteal phase defect. This article explains what the luteal phase means, how long it should last, which symptoms are expected, how progesterone and implantation are connected, what luteal phase defect means in current practice, and when the pattern deserves medical assessment.
Luteal phase meaning: the second half of your cycle
The luteal phase is the interval between ovulation and the first day of the next period. The cycle has two halves separated by ovulation. In the first half, the follicular phase, one follicle in the ovary grows and produces oestrogen, which thickens the endometrium (the lining of the uterus). Once the egg is released, the emptied follicle collapses and reorganises itself into the corpus luteum, and the cycle enters its luteal phase. The dominant hormone switches from oestrogen to progesterone. That single switch explains almost everything women notice in the fortnight before a period, from a rise in waking body temperature to thicker discharge and tender breasts.
The two halves behave differently. Follicular length is variable and responds to stress, illness, travel, thyroid disease and polycystic ovary syndrome, so a cycle that runs long or short is usually long or short in its first half. The luteal phase is comparatively fixed, because the corpus luteum has a built-in lifespan of roughly two weeks unless a pregnancy rescues it. If you know when you ovulated, you can predict your period with reasonable accuracy. If you only know when your last period started, you cannot reliably work backwards to ovulation in a cycle that is irregular. Understanding how ovulation is timed is therefore the starting point.
How long does the luteal phase last, and how do you count it?
Count day one of the luteal phase as the day after ovulation, and the last day as the day before bleeding begins. A normal luteal phase lasts about 11 to 16 days, with 12 to 14 days being typical. A luteal phase of ten days or shorter, repeated over several cycles, is considered short and is worth mentioning to a doctor, particularly if you are trying to conceive. An occasional short luteal phase after an illness, a stressful month or a cycle without ovulation is not unusual and does not by itself indicate a problem. Isolated measurements mislead; the pattern across three or more cycles is what carries information.
- Ovulation predictor kits detect the luteinising hormone surge, which usually precedes egg release by about 24 to 36 hours.
- Basal body temperature rises by roughly 0.3 to 0.5 degrees Celsius after ovulation and stays up while progesterone is high, so it confirms ovulation retrospectively rather than predicting it.
- Cervical mucus becomes clear, slippery and stretchy in the days before ovulation, then abruptly thicker afterwards.
- Ultrasound follicle tracking shows follicle growth, collapse and the developing corpus luteum, and is the most precise method in a clinical setting.
A common misunderstanding is that everyone ovulates on day 14. In a 35-day cycle ovulation is more likely around day 21, and in a 24-day cycle around day 10, yet in both the luteal phase tends to occupy a similar final fortnight. Cycle length therefore tells you more about the follicular phase than the luteal one. If your cycles are consistently shorter than 24 days or longer than 35 days, or if they vary by more than about a week from month to month, the underlying issue is far more often an ovulation problem than a luteal one, and that distinction changes how you are investigated and what treatment is appropriate.
The corpus luteum and progesterone: what is actually happening
After the egg is released, granulosa and theca cells left behind in the collapsed follicle change their function, take up cholesterol and begin producing progesterone in large amounts, along with oestradiol and inhibin A. This structure, the corpus luteum, is maintained by luteinising hormone released in pulses by the pituitary gland. Its lifespan is programmed: without a new signal it degenerates after approximately 12 to 14 days, progesterone falls, the endometrium loses its support, and menstruation follows. The whole luteal phase is therefore best understood as a countdown that only stops if an implanting embryo interrupts it.
That interruption is human chorionic gonadotropin (hCG), produced by the trophoblast, the outer cell layer of the early embryo. hCG binds the same receptor as luteinising hormone and rescues the corpus luteum, so progesterone keeps rising instead of falling and no period occurs. From roughly the seventh to tenth week of pregnancy the placenta gradually takes over progesterone production, a handover known as the luteal-placental shift. This mechanism explains why a pregnancy test only becomes positive towards the end of the luteal phase, and why implantation timing and period timing are so closely linked.
Luteal phase symptoms: what is expected and why
Progesterone has receptors in many tissues outside the uterus, which is why luteal phase symptoms are so varied. It relaxes smooth muscle, which slows bowel transit and causes bloating and constipation. It stimulates breast glandular tissue, producing fullness and tenderness. It raises core temperature by acting on the hypothalamus, which for some women means restless nights and vivid dreams. It also influences salt and water handling through the renin-angiotensin system, contributing to fluid retention. Combined with the fall of both progesterone and oestrogen in the last days before bleeding, this produces the familiar premenstrual cluster.
- Breast fullness, heaviness or tenderness, typically strongest in the last week of the phase
- Abdominal bloating and mild constipation, then looser stools as the period approaches
- Fatigue, increased appetite and carbohydrate craving
- Headache, disturbed sleep, or waking earlier than usual
- Acne flare, oilier skin and mild fluid retention
- Low back or pelvic heaviness and mild cramping in the final days
Symptoms that begin shortly after ovulation, intensify in the last five to seven days and resolve within one to two days of bleeding follow the expected pattern. Symptoms that never fully clear, that worsen year on year, or that include severe pain during periods, pain with intercourse or pain on opening the bowels point elsewhere, most often towards endometriosis or adenomyosis, and deserve examination and imaging rather than reassurance. Severity is also worth recording separately from timing: pain that stops you working or that no longer responds to simple analgesia is not simply a bad premenstrual phase, whatever its rhythm.
Luteal phase discharge: what changes after ovulation
Luteal phase discharge is normally thicker, whiter or creamier and less abundant than the clear, stretchy mucus of the fertile window. Progesterone changes the cervical glands so that mucus becomes viscous and forms a plug, which is a barrier function rather than a fertility signal. Many women describe a sticky or lotion-like discharge from a day or two after ovulation until their period. Some notice almost nothing, which is equally normal. Quantity varies with hydration, sexual activity, contraception and individual physiology, and the absence of visible discharge in the second half of the cycle does not mean progesterone is low.
Certain changes are not part of the luteal phase and need assessment: discharge that becomes grey and fishy-smelling, thick and itchy, green or frothy, or that comes with burning, pelvic pain or fever. Light brown or pink discharge for one day just before a period is common. Brown discharge or spotting that starts several days before the period, cycle after cycle, is worth investigating, because it can reflect a shortened luteal phase, a polyp, adenomyosis or chronic inflammation of the lining rather than a hormone problem alone. Bleeding between periods or after intercourse belongs in the same category and should be examined rather than tracked.
Luteal phase mood: PMS, PMDD and why the brain reacts
Luteal phase mood changes are real and have a physiological basis. Progesterone is converted in the brain to allopregnanolone, a neurosteroid that acts on GABA-A receptors, the same receptor family targeted by sedative medication. Some women respond to this with calm; others become irritable, anxious or tearful, and sensitivity to the change rather than the absolute hormone level appears to determine who is affected. Falling oestrogen in the late luteal phase also lowers serotonin activity. This is why mood commonly dips in the final days rather than immediately after ovulation, and why it lifts sharply once bleeding starts.
Most women report some premenstrual symptoms. A smaller group meet criteria for premenstrual dysphoric disorder (PMDD), in which mood symptoms are severe enough to disrupt work, study or relationships. The defining feature is timing, not intensity alone: symptoms must appear in the luteal phase and remit within a few days of menstruation. Keeping a simple daily rating over two consecutive cycles is the most useful thing a patient can bring to a first appointment, because retrospective recall is unreliable and a prospective diary separates PMDD from depression or anxiety that happens to fluctuate.
Progesterone, the endometrium and the window of implantation
Oestrogen in the follicular phase builds the endometrium and installs progesterone receptors. Progesterone then converts that proliferative lining into a secretory one: glands become tortuous and secrete nutrients, the stromal cells transform in a process called decidualisation, blood vessels remodel, and the surface briefly expresses the adhesion molecules an embryo needs. This receptive state, often called the window of implantation, opens roughly six days after ovulation and lasts a few days. Before it and after it the endometrium actively resists attachment. Timing therefore matters as much as thickness, a point that is central to how the lining is assessed before transfer.
A blastocyst reaching the uterus outside that window cannot attach efficiently even if it is chromosomally normal. In a natural cycle the two are synchronised automatically, since the same event, ovulation, starts both clocks. In assisted reproduction the two clocks are set separately by medication, which is why exact progesterone start times and transfer days are calculated so carefully. Adequate progesterone exposure over the days before transfer is what defines receptivity, and an unusually short or hormonally weak luteal phase can shift or shorten that window. Endometrial receptivity testing has been proposed for women with repeated implantation failure, but it remains an add-on rather than a routine test, and its value is still debated.
Luteal phase defect: what the term means in current practice
Luteal phase defect describes a luteal phase that is too short, or in which progesterone production is insufficient to maintain a secretory endometrium. In theory it would cause difficulty conceiving and early pregnancy loss. In practice the concept is contested, because no test reliably identifies it and no treatment has been shown to correct it in naturally conceiving women. Professional bodies including the American Society for Reproductive Medicine have concluded that luteal phase deficiency, as an independent cause of infertility, cannot be diagnosed with current methods, and it is not part of a standard fertility work-up.
This does not mean the underlying observations are meaningless. A repeatedly short luteal phase is a genuine finding, but it is usually a marker of imperfect ovulation rather than a separate disease: a follicle that developed poorly forms a corpus luteum that works poorly. The clinically productive question is therefore not how to top up progesterone, but why ovulation is suboptimal. Anything that disturbs follicle development will disturb the corpus luteum that follows, so the differential is broad and the assessment should look upstream before a hormone supplement is prescribed.
- Polycystic ovary syndrome, where infrequent ovulation produces long cycles with little or no luteal phase
- Untreated hypothyroidism or raised prolactin, both of which blunt the luteinising hormone surge
- Very low body fat, rapid weight loss or heavy endurance training, which suppress hypothalamic signalling and often shorten the luteal phase before periods stop altogether
- Insulin resistance and poorly controlled diabetes
- The transition towards menopause, in which cycles shorten and ovulation becomes erratic
How the luteal phase is assessed in clinic
Assessment starts with the story: cycle length over several months, the interval between a positive ovulation test and the period, premenstrual spotting, previous pregnancies and losses, medication and weight change. Tests are chosen to answer specific questions rather than to screen indiscriminately, and a single progesterone value is easy to misread. Because progesterone is secreted in pulses, levels can swing several-fold within an hour, so one low number does not establish a deficient corpus luteum, and one reassuring number does not exclude a problem. Interpretation always belongs with the clinician who knows the cycle in question.
- Mid-luteal serum progesterone, drawn about seven days after ovulation, mainly to confirm that ovulation occurred rather than to grade its quality
- Thyroid-stimulating hormone and prolactin, since both influence ovulation and luteal function
- Day 2 to 5 FSH, LH and oestradiol, plus anti-Mullerian hormone, to assess ovarian reserve where relevant
- Transvaginal ultrasound for follicle tracking, endometrial thickness and pattern, and for polyps, fibroids or adenomyosis
- Endometrial biopsy only in selected cases, for example when chronic endometritis is suspected; historical dating of the biopsy to diagnose luteal phase defect has been abandoned as unreliable
Premenstrual spotting is not always hormonal
Bleeding in the days before a period is often attributed to falling progesterone, but structural and inflammatory causes are common and each has a different treatment. An endometrial polyp, a submucosal fibroid, adenomyosis, a caesarean scar niche and chronic endometritis can all produce staining in the late luteal phase, and none of them respond to hormone supplements. This is why a persistently short cycle with premenstrual spotting deserves a pelvic ultrasound rather than an empirical prescription. Bleeding between periods, after intercourse or after the menopause is a separate concern and always needs examination.
The same principle applies to early pregnancy loss. When losses are recurrent, the assessment widens beyond progesterone to include uterine anatomy, thyroid function and thyroid antibodies, blood sugar control, and antiphospholipid syndrome, alongside consideration of chromosomal factors in the couple. Attributing repeated losses to a weak luteal phase without that work-up risks missing a treatable cause, which is discussed further in our article on recurrent miscarriage and implantation failure. Most sporadic early losses reflect chromosomal errors in the embryo rather than anything about the luteal phase, and a single miscarriage does not on its own indicate that hormone support is needed in a future cycle.
The luteal phase in IVF and frozen embryo transfer
In IVF the natural luteal phase is deliberately overridden. The medications used to prevent premature ovulation suppress pituitary hormone release, and the follicles are aspirated at egg collection, so the corpus luteum cannot function normally afterwards. Luteal support with progesterone, given vaginally, by injection or occasionally orally, is therefore routine from around the day of egg collection until the pregnancy test and often for several weeks beyond. This is one of the few settings where progesterone supplementation has a clear, evidence-based rationale, discussed in more detail in our article on luteal support in IVF.
Frozen embryo transfer cycles handle the luteal phase in one of two ways. In a hormone replacement cycle there is no ovulation and no corpus luteum at all, so oestrogen prepares the lining and progesterone is started on a fixed schedule to open the implantation window; the embryo is then thawed and transferred on the matching day. In a natural or modified natural cycle, the woman's own ovulation sets the timing and support may still be added. Which approach is chosen depends on cycle regularity, endometrial response and previous treatment, and that decision rests with your treating physician.
When to seek medical advice
Cyclical premenstrual symptoms that resolve with bleeding rarely need investigation. Seek assessment if your luteal phase is consistently ten days or shorter, if you spot for several days before every period, if cycles are shorter than 24 days or longer than 35 days, if periods stop for three months or more outside pregnancy, or if premenstrual mood symptoms affect your ability to work or maintain relationships. Severe period pain, pain during intercourse, or pain that has been worsening over years should be examined regardless of where it falls in the cycle.
If you are trying to conceive, do not wait indefinitely for a perfect luteal phase. Timing intercourse or insemination to the fertile window matters more than the luteal count, and the usual thresholds for seeking help still apply: twelve months of trying under the age of 35, six months at 35 or above, and earlier if periods are irregular, if there is known endometriosis or previous pelvic surgery, or if a semen analysis has already been abnormal. Any treatment decision, including whether progesterone is appropriate for you, should be made with your own doctor after assessment.
Related Reading
- Ovulation Explained: When It Happens and How to Find Your Fertile Window
- Progesterone and Luteal Phase Support in IVF
- Endometrial Lining and Implantation: What Matters
- After Embryo Transfer: Implantation Symptoms and What to Expect
Sources and references
This article is supported by the following independent, authoritative sources: